Robert Alan Reed, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 150 Tejas Pl, Nipomo, CA 93444 Phone: 805-270-1801 |
Chin Chon Ng Chan Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 610 W Tefft St, Nipomo, CA 93444 Phone: 805-929-2740 |
Dr. Vina Jomarie Famuleras De Vera, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 610 W Tefft St, Nipomo, CA 93444 Phone: 805-929-2740 |
Alexander Irvine, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1145 Oakmont Pl, Nipomo, CA 93444 Phone: 805-929-1732 |
Janghwan Lee, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 610 W Tefft St, Nipomo, CA 93444 Phone: 805-929-2740 |
Binhyen Thai Tran Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 610 W Tefft St, Nipomo, CA 93444 Phone: 805-929-2740 |
Dr. Eva Flynn, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1098 Danni Ct, Nipomo, CA 93444 Phone: 661-747-7656 |
Sailesh Singh Maharjan Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 610 W Tefft St, Nipomo, CA 93444 Phone: 805-929-2740 |
Bo Ram Kim, REGISTERED PHARMACIS Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 520 W Tefft St, Nipomo, CA 93444 Phone: 805-931-1860 |
Sidney Pham, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 610 W Tefft St, Nipomo, CA 93444 Phone: 805-929-2740 Fax: 805-929-3360 |
Mrs. Stacey Austin-pauely, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 520 W Tefft St, Nipomo, CA 93444 Phone: 805-931-1860 Fax: 805-931-1866 |
Karen L. Coyne, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 520 W Tefft St, Nipomo, CA 93444 Phone: 805-931-1860 |
News Archive
PathXchange.org, a global online pathology community, announced the establishment of Case Editorial Boards (CEB) for over 20 pathology subspecialties to promote online participation and to ensure quality content in the portal.
Patients with advanced non-small cell lung cancer whose disease has progressed following chemotherapy have a higher rate of tumor shrinkage and a longer interval before cancer progression when bevacizumab is added to standard second-line erlotinib therapy, according to a study presented at the 2008 Chicago Multidisciplinary Symposium in Thoracic Oncology, sponsored by ASTRO, ASCO, IASLC and the University of Chicago.
In an effort to sign up people for the new health coverage that will become available this fall, Enroll America is one of a number of organizations launching aggressive health law outreach campaigns.
Meanwhile, Texas and Michigan are seeking waivers from the law's medical-loss ratio rule and the Department of Health and Human Services posts information about patients' appeals rights.
Nevro Corp., a medical device company that has developed and commercialized an innovative, evidence-based neuromodulation platform for the treatment of chronic pain, today reported financial results for the three months ended March 31, 2015.
› Verified 9 days ago